Effectiveness of XBB.1.5 Monovalent COVID-19 Vaccines During a Period of XBB.1.5 Dominance in EU/EEA Countries, October to November 2023: A VEBIS-EHR Network Study.
Saved in:
| Title: | Effectiveness of XBB.1.5 Monovalent COVID-19 Vaccines During a Period of XBB.1.5 Dominance in EU/EEA Countries, October to November 2023: A VEBIS-EHR Network Study. |
|---|---|
| Authors: | Monge S; Department of Communicable Diseases, National Centre of Epidemiology, Institute of Health Carlos III, Madrid, Spain.; CIBER on Infectious Diseases, Madrid, Spain., Humphreys J; Epiconcept, Paris, France., Nicolay N; Vaccine Preventable Diseases and Immunisation, European Centre for Disease Prevention and Control (ECDC), Solna, Sweden., Braeye T; Sciensano, Elsene, Belgium., Van Evercooren I; Sciensano, Elsene, Belgium., Holm Hansen C; Department of Infectious Disease Epidemiology and Prevention, Statens Serum Institut, Copenhagen, Denmark., Emborg HD; Department of Infectious Disease Epidemiology and Prevention, Statens Serum Institut, Copenhagen, Denmark., Sacco C; Infectious Diseases Department, Istituto Superiore di Sanità, Rome, Italy.; European Programme on Intervention Epidemiology Training (EPIET), European Centre for Disease Prevention and Control, Stockholm, Sweden., Mateo-Urdiales A; Infectious Diseases Department, Istituto Superiore di Sanità, Rome, Italy., Castilla J; Instituto de Salud Pública de Navarra - IdiSNA, Pamplona, Spain.; CIBER on Epidemiology and Public Health, Madrid, Spain., Martínez-Baz I; Instituto de Salud Pública de Navarra - IdiSNA, Pamplona, Spain.; CIBER on Epidemiology and Public Health, Madrid, Spain., de Gier B; Center for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands., Hahné S; Center for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands., Meijerink H; Norwegian Institute of Public Health (NIPH), Oslo, Norway., Kristoffersen AB; Norwegian Institute of Public Health (NIPH), Oslo, Norway., Machado A; Departamento de Epidemiologia, Instituto Nacional de Saúde Doutor Ricardo Jorge, Lisboa, Portugal., Soares P; Departamento de Epidemiologia, Instituto Nacional de Saúde Doutor Ricardo Jorge, Lisboa, Portugal., Nardone A; Epiconcept, Paris, France., Bacci S; Vaccine Preventable Diseases and Immunisation, European Centre for Disease Prevention and Control (ECDC), Solna, Sweden., Kissling E; Epiconcept, Paris, France., Nunes B; Epiconcept, Paris, France. |
| Corporate Authors: | VEBIS‐EHR Working Group |
| Source: | Influenza and other respiratory viruses [Influenza Other Respir Viruses] 2024 Apr; Vol. 18 (4), pp. e13292. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Wiley Country of Publication: England NLM ID: 101304007 Publication Model: Print Cited Medium: Internet ISSN: 1750-2659 (Electronic) Linking ISSN: 17502640 NLM ISO Abbreviation: Influenza Other Respir Viruses Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1750-2659 |
|---|---|
| DOI: | 10.1111/irv.13292 |
